Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-25-018913
Filing Date
2025-02-03
Accepted
2025-02-03 08:36:05
Documents
45
Period of Report
2025-02-03

Document Format Files

Seq Description Document Type Size
1 6-K d841350d6k.htm 6-K 8825
2 EX-99.1 d841350dex991.htm EX-99.1 50719
3 GRAPHIC g841350ex99_1p10g1.jpg GRAPHIC 117165
4 GRAPHIC g841350ex99_1p11g1.jpg GRAPHIC 305512
5 GRAPHIC g841350ex99_1p12g1.jpg GRAPHIC 273467
6 GRAPHIC g841350ex99_1p13g1.jpg GRAPHIC 263100
7 GRAPHIC g841350ex99_1p14g1.jpg GRAPHIC 415055
8 GRAPHIC g841350ex99_1p15g1.jpg GRAPHIC 347926
9 GRAPHIC g841350ex99_1p16g1.jpg GRAPHIC 114672
10 GRAPHIC g841350ex99_1p17g1.jpg GRAPHIC 174829
11 GRAPHIC g841350ex99_1p18g1.jpg GRAPHIC 234514
12 GRAPHIC g841350ex99_1p19g1.jpg GRAPHIC 239325
13 GRAPHIC g841350ex99_1p1g1.jpg GRAPHIC 167071
14 GRAPHIC g841350ex99_1p20g1.jpg GRAPHIC 65906
15 GRAPHIC g841350ex99_1p21g1.jpg GRAPHIC 95910
16 GRAPHIC g841350ex99_1p22g1.jpg GRAPHIC 220741
17 GRAPHIC g841350ex99_1p23g1.jpg GRAPHIC 346289
18 GRAPHIC g841350ex99_1p24g1.jpg GRAPHIC 345027
19 GRAPHIC g841350ex99_1p25g1.jpg GRAPHIC 91472
20 GRAPHIC g841350ex99_1p26g1.jpg GRAPHIC 316549
21 GRAPHIC g841350ex99_1p27g1.jpg GRAPHIC 428328
22 GRAPHIC g841350ex99_1p28g1.jpg GRAPHIC 112768
23 GRAPHIC g841350ex99_1p29g1.jpg GRAPHIC 241698
24 GRAPHIC g841350ex99_1p2g1.jpg GRAPHIC 621873
25 GRAPHIC g841350ex99_1p30g1.jpg GRAPHIC 405419
26 GRAPHIC g841350ex99_1p31g1.jpg GRAPHIC 337103
27 GRAPHIC g841350ex99_1p32g1.jpg GRAPHIC 349546
28 GRAPHIC g841350ex99_1p33g1.jpg GRAPHIC 436214
29 GRAPHIC g841350ex99_1p34g1.jpg GRAPHIC 388637
30 GRAPHIC g841350ex99_1p35g1.jpg GRAPHIC 84252
31 GRAPHIC g841350ex99_1p36g1.jpg GRAPHIC 299856
32 GRAPHIC g841350ex99_1p37g1.jpg GRAPHIC 279361
33 GRAPHIC g841350ex99_1p38g1.jpg GRAPHIC 370835
34 GRAPHIC g841350ex99_1p39g1.jpg GRAPHIC 289308
35 GRAPHIC g841350ex99_1p3g1.jpg GRAPHIC 348198
36 GRAPHIC g841350ex99_1p40g1.jpg GRAPHIC 96033
37 GRAPHIC g841350ex99_1p41g1.jpg GRAPHIC 363280
38 GRAPHIC g841350ex99_1p42g1.jpg GRAPHIC 302814
39 GRAPHIC g841350ex99_1p43g1.jpg GRAPHIC 79860
40 GRAPHIC g841350ex99_1p4g1.jpg GRAPHIC 355397
41 GRAPHIC g841350ex99_1p5g1.jpg GRAPHIC 255515
42 GRAPHIC g841350ex99_1p6g1.jpg GRAPHIC 291122
43 GRAPHIC g841350ex99_1p7g1.jpg GRAPHIC 111107
44 GRAPHIC g841350ex99_1p8g1.jpg GRAPHIC 235076
45 GRAPHIC g841350ex99_1p9g1.jpg GRAPHIC 347919
  Complete submission text file 0001193125-25-018913.txt   15995186
Mailing Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW C3 2000
Business Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW C3 2000 01161298780088
KAZIA THERAPEUTICS LTD (Filer) CIK: 0001075880 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 000-29962 | Film No.: 25580742
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)